Integrum AB (OSTO:INTEG B) Notes Receivable: kr0.00 Mil (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:INTEG B Integrum AB OSTO:INTEG B
53 GF Score
Price kr7.96
GF Value kr17.75
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Integrum AB Notes Receivable?

Integrum AB OSTO:INTEG B -2.45% 53 Notes Receivable is kr0.00 Mil as of Apr. 2026. GuruFocus rates OSTO:INTEG B with a GF Score™ of 53/100 and a GF Value™ of kr17.75 (Possible Value Trap). The stock has 4 warning signs investors should review.

Integrum AB's Notes Receivable for the quarter that ended in Apr. 2026 was kr0.00 Mil.

Integrum AB Notes Receivable Historical Data

* Premium members only.

The historical data trend for Integrum AB's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integrum AB Notes Receivable Chart

Integrum AB Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Integrum AB Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
OSTO:INTEG B
53GF Score
Integrum AB OSTO:INTEG B
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integrum AB Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of kr0.00 Mil mean?
Integrum AB (OSTO:INTEG B) has a Notes Receivable of kr0.00 Mil as of Apr. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Integrum AB and its competitors.
Is Integrum AB's Notes Receivable too high?
Integrum AB's current Notes Receivable is kr0.00 Mil. Overall, Integrum AB has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Integrum AB's Notes Receivable compare to ABT and SYK?
Integrum AB's Notes Receivable of kr0.00 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Integrum AB and its competitors. Integrum AB's current Notes Receivable is kr0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integrum AB stock overvalued right now?
Based on GuruFocus' analysis, Integrum AB (OSTO:INTEG B) is currently considered Possible Value Trap. The stock's GF Value™ is kr17.75, compared to a current price of kr7.96 — trading 55.2% below its estimated fair value. The current Notes Receivable is kr0.00 Mil. Integrum AB's overall GF Score™ is 53/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Integrum AB (OSTO:INTEG B), the current Notes Receivable is kr0.00 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integrum AB (OSTO:INTEG B) Overvalued in 2026?

Based on GuruFocus' analysis, Integrum AB stock appears to be undervalued. The current stock price of kr7.96 is trading 55.2% below its estimated GF Value™ of kr17.75. GuruFocus considers Integrum AB to be Possible Value Trap.

Key valuation signals for OSTO:INTEG B:

  • Notes Receivable: kr0.00 Mil
  • GF Value™: kr17.75 vs. price of kr7.96 (55.2% below fair value)
  • GF Score™: 53/100 with 4 warning signs

No single metric tells the full story. See the OSTO:INTEG B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Integrum AB Business Description

Other Exchanges 6Y1:Germany
Address Krokslatts Fabriker 50, Molndal, SWE, SE-431 37
Integrum AB provides the system for bone-anchored prostheses that improves the lives of people with amputations. Its solutions include OPRA implant system, Neural prosthetics, Phantom limb pain treatment, and Prosthetic components. The company is also engaged in developing technology for mind-controlled prostheses and treatment for phantom limb pain.
53GF Score

Get the complete analysis for OSTO:INTEG B

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr7.96
Price
kr17.75
GF Value